ID   TERA_RAT                Reviewed;         806 AA.
AC   P46462;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 211.
DE   RecName: Full=Transitional endoplasmic reticulum ATPase;
DE            Short=TER ATPase;
DE            EC=3.6.4.6 {ECO:0000250|UniProtKB:P55072};
DE   AltName: Full=15S Mg(2+)-ATPase p97 subunit;
DE   AltName: Full=Valosin-containing protein;
DE            Short=VCP;
GN   Name=Vcp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7806566; DOI=10.1083/jcb.127.6.1871;
RA   Zhang L., Ashendel C.L., Becker G.W., Morre D.J.;
RT   "Isolation and characterization of the principal ATPase associated with
RT   transitional endoplasmic reticulum of rat liver.";
RL   J. Cell Biol. 127:1871-1883(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 46-53; 149-155; 192-210; 218-225; 240-251; 296-312;
RP   366-386; 454-465; 616-638; 669-677 AND 701-709, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Diao W.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [4]
RP   INTERACTION WITH STX5A.
RX   PubMed=9506515; DOI=10.1016/s0092-8674(00)81128-9;
RA   Rabouille C., Kondo H., Newman R., Hui N., Freemont P., Warren G.;
RT   "Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly
RT   pathways of Golgi cisternae from mitotic Golgi fragments in vitro.";
RL   Cell 92:603-610(1998).
RN   [5]
RP   INTERACTION WITH NPLOC4; UFD1; NSFL1C AND UBE4B, AND SUBCELLULAR LOCATION.
RX   PubMed=10811609; DOI=10.1093/emboj/19.10.2181;
RA   Meyer H.H., Shorter J.G., Seemann J., Pappin D., Warren G.;
RT   "A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to
RT   ubiquitin and nuclear transport pathways.";
RL   EMBO J. 19:2181-2192(2000).
RN   [6]
RP   FUNCTION.
RX   PubMed=10930451; DOI=10.1091/mbc.11.8.2529;
RA   Roy L., Bergeron J.J.M., Lavoie C., Hendriks R., Gushue J., Fazel A.,
RA   Pelletier A., Morre D.J., Subramaniam V.N., Hong W., Paiement J.;
RT   "Role of p97 and syntaxin 5 in the assembly of transitional endoplasmic
RT   reticulum.";
RL   Mol. Biol. Cell 11:2529-2542(2000).
RN   [7]
RP   INTERACTION WITH MEMBRANES.
RX   PubMed=12146947; DOI=10.1021/bi0259195;
RA   Pecheur E.-I., Martin I., Maier O., Bakowsky U., Ruysschaert J.-M.,
RA   Hoekstra D.;
RT   "Phospholipid species act as modulators in p97/p47-mediated fusion of Golgi
RT   membranes.";
RL   Biochemistry 41:9813-9823(2002).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH NSFL1C; NAP1L4 AND UFD1.
RX   PubMed=12411482; DOI=10.1093/emboj/cdf579;
RA   Meyer H.H., Wang Y., Warren G.;
RT   "Direct binding of ubiquitin conjugates by the mammalian p97 adaptor
RT   complexes, p47 and Ufd1-Npl4.";
RL   EMBO J. 21:5645-5652(2002).
RN   [9]
RP   INTERACTION WITH VCIP135.
RX   PubMed=12473691; DOI=10.1083/jcb.200208112;
RA   Uchiyama K., Jokitalo E., Kano F., Murata M., Zhang X., Canas B.,
RA   Newman R., Rabouille C., Pappin D., Freemont P., Kondo H.;
RT   "VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is
RT   required for Golgi and ER assembly in vivo.";
RL   J. Cell Biol. 159:855-866(2002).
RN   [10]
RP   PHOSPHORYLATION.
RX   PubMed=12810701; DOI=10.1083/jcb.200303048;
RA   Uchiyama K., Jokitalo E., Lindman M., Jackman M., Kano F., Murata M.,
RA   Zhang X., Kondo H.;
RT   "The localization and phosphorylation of p47 are important for Golgi
RT   disassembly-assembly during the cell cycle.";
RL   J. Cell Biol. 161:1067-1079(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND SER-7, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH STUB1; UBXN2A AND CHRNA3, AND
RP   INTERACTION WITH UBXN2A.
RX   PubMed=26265139; DOI=10.1016/j.bcp.2015.08.084;
RA   Teng Y., Rezvani K., De Biasi M.;
RT   "UBXN2A regulates nicotinic receptor degradation by modulating the E3
RT   ligase activity of CHIP.";
RL   Biochem. Pharmacol. 97:518-530(2015).
CC   -!- FUNCTION: Necessary for the fragmentation of Golgi stacks during
CC       mitosis and for their reassembly after mitosis. Involved in the
CC       formation of the transitional endoplasmic reticulum (tER). The transfer
CC       of membranes from the endoplasmic reticulum to the Golgi apparatus
CC       occurs via 50-70 nm transition vesicles which derive from part-rough,
CC       part-smooth transitional elements of the endoplasmic reticulum (tER)
CC       (PubMed:10930451, PubMed:12411482). Vesicle budding from the tER is an
CC       ATP-dependent process (PubMed:10930451, PubMed:12411482). The ternary
CC       complex containing UFD1, VCP and NPLOC4 binds ubiquitinated proteins
CC       and is necessary for the export of misfolded proteins from the ER to
CC       the cytoplasm, where they are degraded by the proteasome
CC       (PubMed:10930451, PubMed:12411482). The NPLOC4-UFD1-VCP complex
CC       regulates spindle disassembly at the end of mitosis and is necessary
CC       for the formation of a closed nuclear envelope. Regulates E3 ubiquitin-
CC       protein ligase activity of RNF19A. Component of the VCP/p97-AMFR/gp78
CC       complex that participates in the final step of the sterol-mediated
CC       ubiquitination and endoplasmic reticulum-associated degradation (ERAD)
CC       of HMGCR. Mediates the endoplasmic reticulum-associated degradation of
CC       CHRNA3 in cortical neurons as part of the STUB1-VCP-UBXN2A complex
CC       (PubMed:26265139). Involved in endoplasmic reticulum stress-induced
CC       pre-emptive quality control, a mechanism that selectively attenuates
CC       the translocation of newly synthesized proteins into the endoplasmic
CC       reticulum and reroutes them to the cytosol for proteasomal degradation.
CC       Involved in clearance process by mediating G3BP1 extraction from stress
CC       granules (By similarity). Also involved in DNA damage response:
CC       recruited to double-strand breaks (DSBs) sites in a RNF8- and RNF168-
CC       dependent manner and promotes the recruitment of TP53BP1 at DNA damage
CC       sites. Recruited to stalled replication forks by SPRTN: may act by
CC       mediating extraction of DNA polymerase eta (POLH) to prevent excessive
CC       translesion DNA synthesis and limit the incidence of mutations induced
CC       by DNA damage. Together with SPRTN metalloprotease, involved in the
CC       repair of covalent DNA-protein cross-links (DPCs) during DNA synthesis.
CC       Involved in interstrand cross-link repair in response to replication
CC       stress by mediating unloading of the ubiquitinated CMG helicase
CC       complex. Mediates extraction of PARP1 trapped to chromatin: recognizes
CC       and binds ubiquitinated PARP1 and promotes its removal (By similarity).
CC       Required for cytoplasmic retrotranslocation of stressed/damaged
CC       mitochondrial outer-membrane proteins and their subsequent proteasomal
CC       degradation. Essential for the maturation of ubiquitin-containing
CC       autophagosomes and the clearance of ubiquitinated protein by autophagy.
CC       Acts as a negative regulator of type I interferon production by
CC       interacting with RIGI: interaction takes place when RIGI is
CC       ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains,
CC       leading to recruit RNF125 and promote ubiquitination and degradation of
CC       RIGI (By similarity). May play a role in the ubiquitin-dependent
CC       sorting of membrane proteins to lysosomes where they undergo
CC       degradation (By similarity). May more particularly play a role in
CC       caveolins sorting in cells (By similarity). By controlling the steady-
CC       state expression of the IGF1R receptor, indirectly regulates the
CC       insulin-like growth factor receptor signaling pathway (By similarity).
CC       {ECO:0000250|UniProtKB:P23787, ECO:0000250|UniProtKB:P55072,
CC       ECO:0000269|PubMed:10930451, ECO:0000269|PubMed:12411482,
CC       ECO:0000269|PubMed:26265139}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.6;
CC         Evidence={ECO:0000250|UniProtKB:P55072};
CC   -!- SUBUNIT: Homohexamer. Forms a ring-shaped particle of 12.5 nm diameter,
CC       that displays 6-fold radial symmetry. Interacts with NSFL1C-like
CC       protein p37; the complex has membrane fusion activity and is required
CC       for Golgi and endoplasmic reticulum biogenesis. Interacts with RHBDD1
CC       (via C-terminal domain). Interacts with SELENOS and SYVN1, as well as
CC       with DERL1 (via SHP-box motif), DERL2 and DERL3; which probably
CC       transfer misfolded proteins from the ER to VCP. Interacts with SVIP.
CC       Component of a complex required to couple retrotranslocation,
CC       ubiquitination and deglycosylation composed of NGLY1, SAKS1, AMFR, VCP
CC       and RAD23B. Part of a complex composed of STUB1/CHIP, VCP/p97, CHRNA3,
CC       and UBXN2A that modulates the ubiquitination and endoplasmic reticulum-
CC       associated degradation (ERAD) of CHRNA3 (PubMed:26265139). Within the
CC       complex UBXN2A acts as a scaffold protein required for the interaction
CC       of CHRNA3 with VCP/p97, this interaction also inhibits CHRNA3
CC       ubiquitination by STUB1/CHIP and subsequently ERAD (PubMed:26265139).
CC       Interacts with UBXN2A (via UBX domain); the interaction is required for
CC       the interaction of CHRNA3 in the STUB1-VCP-UBXN2A complex
CC       (PubMed:26265139). Directly interacts with UBXN4 and RNF19A. Interacts
CC       with CASR. Interacts with UBE4B and YOD1. Interacts with clathrin.
CC       Interacts with RNF103. Interacts with TRIM13 and TRIM21. Component of a
CC       VCP/p97-AMFR/gp78 complex that participates in the final step of the
CC       endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Interacts
CC       directly with AMFR/gp78 (via its VIM). Interacts with SPRTN; leading to
CC       recruitment to stalled replication forks. Part of a ternary complex
CC       containing STX5A, NSFL1C and VCP. NSFL1C forms a homotrimer that binds
CC       to one end of a VCP homohexamer. The complex binds to membranes
CC       enriched in phosphatidylethanolamine-containing lipids and promotes
CC       Golgi membrane fusion. Binds to a heterodimer of NPLOC4 and UFD1,
CC       binding to this heterodimer inhibits Golgi-membrane fusion. Interaction
CC       with VCIP135 leads to dissociation of the complex via ATP hydrolysis by
CC       VCP. Part of a ternary complex containing NPLOC4, UFD1 and VCP.
CC       Interacts with WASHC5. Interacts with UBOX5. Interacts (via N-terminus)
CC       with UBXN7, UBXN8, and probably several other UBX domain-containing
CC       proteins (via UBX domains); the interactions are mutually exclusive
CC       with VIM-dependent interactions such as those with AMFR and SELENOS.
CC       Forms a complex with UBQLN1 and UBXN4 (By similarity). Interacts (via
CC       the PIM motif) with RNF31 (via the PUB domain) (By similarity).
CC       Interacts with RIGI and RNF125; interaction takes place when RIGI is
CC       ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains,
CC       leading to recruit RNF125 and promote ubiquitination and degradation of
CC       RIGI (By similarity). Interacts with BAG6 (By similarity). Interacts
CC       with UBXN10 (By similarity). Interacts with UBXN6; the interaction with
CC       UBXN6 is direct and competitive with UFD1 (By similarity). Forms a
CC       ternary complex with CAV1 and UBXN6. Interacts with PLAA, UBXN6 and
CC       YOD1; may form a complex involved in macroautophagy (By similarity).
CC       Interacts with ANKZF1 (By similarity). Interacts with ubiquitin-binding
CC       protein FAF1 (By similarity). Interacts with ZFAND2B (via VIM motif);
CC       the interaction is direct (By similarity). Interacts with ZFAND1 (via
CC       its ubiquitin-like region); this interaction occurs in an arsenite-
CC       dependent manner (By similarity). Interacts with CCDC47 (By
CC       similarity). Interacts with LMBR1L and UBAC2 (By similarity). Interacts
CC       with ATXN3 (By similarity). Interacts with TEX264; bridging VCP to
CC       covalent DNA-protein cross-links (DPCs) (By similarity).
CC       {ECO:0000250|UniProtKB:P55072, ECO:0000250|UniProtKB:Q01853,
CC       ECO:0000269|PubMed:10811609, ECO:0000269|PubMed:12411482,
CC       ECO:0000269|PubMed:12473691, ECO:0000269|PubMed:26265139,
CC       ECO:0000269|PubMed:9506515}.
CC   -!- INTERACTION:
CC       P46462; O35987: Nsfl1c; NbExp=12; IntAct=EBI-399011, EBI-1993760;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10811609}.
CC       Endoplasmic reticulum {ECO:0000250|UniProtKB:P55072}. Nucleus
CC       {ECO:0000269|PubMed:10811609}. Cytoplasm, Stress granule
CC       {ECO:0000250|UniProtKB:P55072}. Note=Recruited to the cytoplasmic
CC       surface of the endoplasmic reticulum via interaction with AMFR/gp78.
CC       Following DNA double-strand breaks, recruited to the sites of damage.
CC       Recruited to stalled replication forks via interaction with SPRTN.
CC       Recruited to damaged lysosomes decorated with K48-linked ubiquitin
CC       chains. Colocalizes with TIA1, ZFAND1 and G3BP1 in cytoplasmic stress
CC       granules (SGs) in response to arsenite-induced stress treatment (By
CC       similarity). {ECO:0000250|UniProtKB:P55072}.
CC   -!- DOMAIN: The PIM (PUB-interaction motif) motif mediates interaction with
CC       the PUB domain of RNF31. {ECO:0000250|UniProtKB:P55072}.
CC   -!- PTM: Phosphorylated by tyrosine kinases in response to T-cell antigen
CC       receptor activation. Phosphorylated in mitotic cells.
CC       {ECO:0000269|PubMed:12810701}.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P55072}.
CC   -!- PTM: Methylation at Lys-315 catalyzed by VCPKMT is increased in the
CC       presence of ASPSCR1. Lys-315 methylation may decrease ATPase activity.
CC       {ECO:0000250|UniProtKB:P55072}.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U11760; AAC52154.1; -; mRNA.
DR   EMBL; BC060518; AAH60518.1; -; mRNA.
DR   PIR; A55190; A55190.
DR   RefSeq; NP_446316.1; NM_053864.2.
DR   AlphaFoldDB; P46462; -.
DR   SMR; P46462; -.
DR   BioGRID; 250528; 29.
DR   ComplexPortal; CPX-138; Vcp-Npl4-Ufd1 AAA ATPase complex.
DR   ComplexPortal; CPX-263; Vcp-Nsfl1c AAA ATPase complex.
DR   CORUM; P46462; -.
DR   IntAct; P46462; 12.
DR   MINT; P46462; -.
DR   STRING; 10116.ENSRNOP00000040121; -.
DR   GlyGen; P46462; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P46462; -.
DR   PhosphoSitePlus; P46462; -.
DR   SwissPalm; P46462; -.
DR   jPOST; P46462; -.
DR   PaxDb; 10116-ENSRNOP00000040121; -.
DR   Ensembl; ENSRNOT00000046102.3; ENSRNOP00000040121.2; ENSRNOG00000034242.4.
DR   Ensembl; ENSRNOT00055027816; ENSRNOP00055022342; ENSRNOG00055016411.
DR   Ensembl; ENSRNOT00060008072; ENSRNOP00060006045; ENSRNOG00060004848.
DR   Ensembl; ENSRNOT00065007042; ENSRNOP00065004855; ENSRNOG00065004846.
DR   GeneID; 116643; -.
DR   KEGG; rno:116643; -.
DR   UCSC; RGD:621595; rat.
DR   AGR; RGD:621595; -.
DR   CTD; 7415; -.
DR   RGD; 621595; Vcp.
DR   eggNOG; KOG0730; Eukaryota.
DR   GeneTree; ENSGT00900000141071; -.
DR   HOGENOM; CLU_000688_12_3_1; -.
DR   InParanoid; P46462; -.
DR   OMA; HACHDIK; -.
DR   OrthoDB; 168438at2759; -.
DR   PhylomeDB; P46462; -.
DR   TreeFam; TF300542; -.
DR   BRENDA; 3.6.4.6; 5301.
DR   Reactome; R-RNO-110320; Translesion Synthesis by POLH.
DR   Reactome; R-RNO-3371511; HSF1 activation.
DR   Reactome; R-RNO-382556; ABC-family proteins mediated transport.
DR   Reactome; R-RNO-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   Reactome; R-RNO-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-RNO-5689877; Josephin domain DUBs.
DR   Reactome; R-RNO-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-8951664; Neddylation.
DR   Reactome; R-RNO-9013407; RHOH GTPase cycle.
DR   Reactome; R-RNO-9755511; KEAP1-NFE2L2 pathway.
DR   PRO; PR:P46462; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000034242; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:1904949; C:ATPase complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0036513; C:Derlin-1 retrotranslocation complex; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005811; C:lipid droplet; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0000502; C:proteasome complex; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0035861; C:site of double-strand break; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990730; C:VCP-NSFL1C complex; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0043531; F:ADP binding; IMP:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:RGD.
DR   GO; GO:1904288; F:BAT3 complex binding; ISO:RGD.
DR   GO; GO:0035800; F:deubiquitinase activator activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IDA:BHF-UCL.
DR   GO; GO:0036435; F:K48-linked polyubiquitin modification-dependent protein binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0042288; F:MHC class I protein binding; ISO:RGD.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; ISO:RGD.
DR   GO; GO:0140036; F:ubiquitin-modified protein reader activity; ISO:RGD.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; ISO:RGD.
DR   GO; GO:0070842; P:aggresome assembly; ISO:RGD.
DR   GO; GO:0046034; P:ATP metabolic process; ISO:RGD.
DR   GO; GO:0097352; P:autophagosome maturation; ISS:UniProtKB.
DR   GO; GO:0006914; P:autophagy; ISS:UniProtKB.
DR   GO; GO:1903843; P:cellular response to arsenite ion; ISS:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:0071218; P:cellular response to misfolded protein; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; ISS:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; ISS:UniProtKB.
DR   GO; GO:0061857; P:endoplasmic reticulum stress-induced pre-emptive quality control; ISS:UniProtKB.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; IMP:RGD.
DR   GO; GO:0032510; P:endosome to lysosome transport via multivesicular body sorting pathway; ISS:UniProtKB.
DR   GO; GO:0036503; P:ERAD pathway; IDA:ComplexPortal.
DR   GO; GO:0072389; P:flavin adenine dinucleotide catabolic process; ISO:RGD.
DR   GO; GO:0036297; P:interstrand cross-link repair; ISS:UniProtKB.
DR   GO; GO:0016236; P:macroautophagy; ISS:UniProtKB.
DR   GO; GO:0051228; P:mitotic spindle disassembly; IBA:GO_Central.
DR   GO; GO:0006734; P:NADH metabolic process; ISO:RGD.
DR   GO; GO:0120186; P:negative regulation of protein localization to chromatin; ISO:RGD.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISO:RGD.
DR   GO; GO:2001171; P:positive regulation of ATP biosynthetic process; ISO:RGD.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0010918; P:positive regulation of mitochondrial membrane potential; ISO:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:1903862; P:positive regulation of oxidative phosphorylation; ISO:RGD.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:1903006; P:positive regulation of protein K63-linked deubiquitination; ISO:RGD.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; ISO:RGD.
DR   GO; GO:2000060; P:positive regulation of ubiquitin-dependent protein catabolic process; IMP:RGD.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0106300; P:protein-DNA covalent cross-linking repair; ISS:UniProtKB.
DR   GO; GO:1903715; P:regulation of aerobic respiration; ISO:RGD.
DR   GO; GO:1905634; P:regulation of protein localization to chromatin; ISS:UniProtKB.
DR   GO; GO:0050807; P:regulation of synapse organization; IDA:SynGO.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; EXP:ComplexPortal.
DR   GO; GO:0035617; P:stress granule disassembly; ISS:UniProtKB.
DR   GO; GO:0019985; P:translesion synthesis; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0019079; P:viral genome replication; ISO:RGD.
DR   CDD; cd19519; RecA-like_CDC48_r1-like; 1.
DR   CDD; cd19528; RecA-like_CDC48_r2-like; 1.
DR   Gene3D; 1.10.8.60; -; 1.
DR   Gene3D; 2.40.40.20; -; 1.
DR   Gene3D; 3.10.330.10; -; 1.
DR   Gene3D; 6.10.20.150; -; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR005938; AAA_ATPase_CDC48.
DR   InterPro; IPR050168; AAA_ATPase_domain.
DR   InterPro; IPR041569; AAA_lid_3.
DR   InterPro; IPR009010; Asp_de-COase-like_dom_sf.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR004201; Cdc48_dom2.
DR   InterPro; IPR029067; CDC48_domain_2-like_sf.
DR   InterPro; IPR003338; CDC4_N-term_subdom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   NCBIfam; TIGR01243; CDC48; 1.
DR   PANTHER; PTHR23077; AAA-FAMILY ATPASE; 1.
DR   PANTHER; PTHR23077:SF69; TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE; 1.
DR   Pfam; PF00004; AAA; 2.
DR   Pfam; PF17862; AAA_lid_3; 2.
DR   Pfam; PF02933; CDC48_2; 1.
DR   Pfam; PF02359; CDC48_N; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM01072; CDC48_2; 1.
DR   SMART; SM01073; CDC48_N; 1.
DR   SUPFAM; SSF50692; ADC-like; 1.
DR   SUPFAM; SSF54585; Cdc48 domain 2-like; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS00674; AAA; 2.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Autophagy; Cytoplasm; Direct protein sequencing;
KW   DNA damage; DNA repair; Endoplasmic reticulum; Hydrolase; Isopeptide bond;
KW   Lipid-binding; Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transport; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   CHAIN           2..806
FT                   /note="Transitional endoplasmic reticulum ATPase"
FT                   /id="PRO_0000084575"
FT   REGION          708..727
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          768..806
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          797..806
FT                   /note="Interaction with UBXN6"
FT                   /evidence="ECO:0000250"
FT   MOTIF           802..806
FT                   /note="PIM motif"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   COMPBIAS        768..794
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         247..253
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   BINDING         348
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   BINDING         384
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   BINDING         521..526
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q01853"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         315
FT                   /note="N6,N6,N6-trimethyllysine; by VCPKMT"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         436
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         462
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         502
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01853"
FT   MOD_RES         505
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01853"
FT   MOD_RES         668
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01853"
FT   MOD_RES         668
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01853"
FT   MOD_RES         702
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         754
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01853"
FT   MOD_RES         770
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         775
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         787
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   MOD_RES         805
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01853"
FT   CROSSLNK        8
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
FT   CROSSLNK        18
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P55072"
SQ   SEQUENCE   806 AA;  89349 MW;  501B721D205EBA8A CRC64;
     MASGADSKGD DLSTAILKQK NRPNRLIVDE AINEDNSVVS LSQPKMDELQ LFRGDTVLLK
     GKKRREAVCI VLSDDTCSDE KIRMNRVVRN NLRVRLGDVI SIQPCPDVKY GKRIHVLPID
     DTVEGITGNL FEVYLKPYFL EAYRPIRKGD IFLVRGGMRA VEFKVVETDP SPYCIVAPDT
     VIHCEGEPIK REDEEESLNE VGYDDIGGCR KQLAQIKEMV ELPLRHPALF KAIGVKPPRG
     ILLYGPPGTG KTLIARAVAN ETGAFFFLIN GPEIMSKLAG ESESNLRKAF EEAEKNAPAI
     IFIDELDAIA PKREKTHGEV ERRIVSQLLT LMDGLKQRAH VIVMAATNRP NSIDPALRRF
     GRFDREVDIG IPDATGRLEI LQIHTKNMKL ADDVDLEQVA NETHGHVGAD LAALCSEAAL
     QAIRKKMDLI DLEDETIDAE VMNSLAVTMD DFRWALSQSN PSALRETVVE VPQVTWEDIG
     GLEDVKRELQ ELVQYPVEHP DKFLKFGMTP SKGVLFYGPP GCGKTLLAKA IANECQANFI
     SIKGPELLTM WFGESEANVR EIFDKARQAA PCVLFFDELD SIAKARGGNI GDGGGAADRV
     INQILTEMDG MSTKKNVFII GATNRPDIID PAILRPGRLD QLIYIPLPDE KSRVAILKAN
     LRKSPVAKDV DLEFLAKMTN GFSGADLTEI CQRACKLAIR ESIESEIRRE RERQTNPSAM
     EVEEDDPVPE IRRDHFEEAM RFARRSVSDN DIRKYEMFAQ TLQQSRGFGS FRFPSGNQGG
     AGPSQGSGGG TGGNVYTEDN DDDLYG
//
